The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model

Pigment Cell Research

Volumn 18, Issue 4, 2005, Pages 315-319

  Ackermann, Julien ^a   Beermann, Friedrich ^a  

^a National Center of Competence in Research in Molecular Oncology   (Switzerland)

Author keywords

FGF2; Knockout; Melanocyte; N ras; Transgenic; Tyrosinase

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; PROTEIN P16INK4A; PROTEIN P19;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; HYPERPIGMENTATION; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; ONCOGENE N RAS; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLAST GROWTH FACTOR 2; GENES, RAS; HUMANS; MELANOCYTES; MELANOMA; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF;

MUS MUSCULUS;

EID: 22744451967     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2005.00243.x     Document Type: Article

References (33)

1. Ackermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., and Beermann, F. (2005). Metastasizing melanoma formation caused by expression of activated N-rasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005-4011.
2. Alanko, T., Rosenberg, M., and Saksela, O. (1999). FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J. Invest. Dermatol. 113, 111-116.
3. Berking, C., Takemoto, R., Satyamoorthy, K., Elenitsas, R., and Herlyn, M. (2001). Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am. J. Pathol. 158, 943-953.
4. Berking, C., Takemoto, R., Satyamoorthy, K., Shirakawa, T., Eskandarpour, M., Hansson, J., VanBelle, P., Elder, D., and Herlyn, M. (2004). Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res. 64, 807-811.
5. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D. (1997). Biological roles of fibroblast growth factor-2. Endocrine Rev. 18, 26-45.
6. Compagni, A., Wilgenbus, P., Impagnatiello, M., Cotten, M., and Christofori, G. (2000). Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res. 60, 7163-7169.
7. Dailey, L., Ambrosetti, D., Mansukhani, A., and Basilico, C. (2005). Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Rev. 16, 233-247.
8. Dotto, G.P., Moellmann, G., Ghosh, S., Edwards, M., and Halaban, R. (1989). Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol. 109, 3115-3128.
9. Foletti, A., Ackermann, J., Schmidt, A., Hummler, E., and Beermann, F. (2002). Absence of fibroblast growth factor 2 does not prevent tumor formation originating from the RPE. Oncogene 21, 1841-1847.
10. Foletti, A., Vuadens, F., and Beermann, F. (2003). Nuclear localization of mouse fibroblast growth factor 2 requires N-terminal and C-terminal sequences. Cell Mol. Life Sci. 60, 2254-2265.
11. Graeven, U., Rodeck, U., Karpinski, S., Jost, M., Phlippou, S., and Schmiegel, W. (2001). Modulation of angiogenesis and tumorigenicity of human melanoytic cells by vascular endothelial growth factor and basic fibroblast growth factor. Cancer Res. 61, 7282-7290.
12. Halaban, R., Langdon, R., Birchall, N., Cuono, C., Baird, A., Scott, G., Moellmann, G., and McGuir, J. (1988). Basic fibroblast growth factor of keratinocytes is a natural mitogen for human melanocytes. J. Cell. Biol. 107, 1611-1619.
13. Hanahan, D., and Folkman, J. (1995). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
14. Meier, F., Caroli, U., Satyamoorthy, K. et al. (2003). Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promote progression of melanocytes to melanoma. Exp. Dermatol. 12, 296-306.
15. Nesbit, M., Nesbit, H., Bennett, J., Andl, T., Hsu, M., Dejesus, E., McBrian, M., Gupta, A., Eck, S., and Herlyn, M. (1999). Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18, 6469-6476.
16. Ortega, S., Ittmann, M., Tsang, S., Ehrlich, M., and Basilico, C. (1998). Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. U.S.A. 95, 5672-5677.
17. Ozen, M., Medrano, E., and Ittmann, M. (2004). Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor. Melanoma Res. 14, 13-21.
18. Pellieux, C., Foletti, A., Peduto, G., Aubert, J.F., Nussberger, J., Beermann, F., Brunner, H.R., and Pedrazzini, T. (2001). Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin 11 in mice lacking FGF-2. J. Clin. Invest. 108, 1843-1851.
19. Polnaszek, N., Kwabi-Addo, B., Peterson, L., Ozen, M., Greenberg, N., Ortega, S., Basilico, C., and Ittmann, M. (2003). Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res. 63, 5754-5760.
20. Reed, J.A., McNutt, N.S., and Albino, A.P. (1994). Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Am. J. Pathol. 144, 329-335.
21. Ribatti, D., Vacca, A., Ria, R., Marzullo, A., Nico, B., Filotico, R., Roncali, L., and Dammaco, F. (2003). Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer. 39, 666-674.
22. Rosenblatt-Velin, N., Lepore, M., Cartoni, C., Beermann, F., and Pedrazzini, T. (2005). The fibroblast growth factor-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J. Clin. Invest, doi: 10.1172/JCI23418.
23. Rousseau, B., Larrieu-Lahargue, F., Guilhem-Ducléon, F., Beermann, F., Javerzat, S., and Bikfalvi, A. (2004). The tyrp1-Tag/ tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity. Cancer Res. 64, 2490-2495.
24. Schlessinger, J. (2004). Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306, 1506-1507.
25. Scott, G., Stoler, M., Sarkar, S., and Halaban, R. (1991). Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. J. Invest. Dermatol. 96, 318-322.
26. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4A locus in tumor suppression and cell mortality. Cell 85, 27-37.
27. Thomas-Mudge, R., Okada-Ban, M., Vandenbroucke, F., Vincent-Salomon, A., Girault, J., Thiery, J., and Jouanneau, J. (2004). Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases. Oncogene 23, 4771-4779.
28. Vagner, S., Touriol, C., Galy, B., Audigier, S., Gensac, M., Amalric, F., Bayard, F., Prats, H., and Prats, A. (1996). Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell. Biol. 135, 1391-1402.
29. Valesky, M., Spang, A., Fisher, G., Farkas, D., and Becker, D. (2002). Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis. Mol. Med. 8, 103-112.
30. Vandermoere, F., El Yazidi-Belkoura, I., Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2005). The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-κB activation induced via interaction between Akt and IκB kinase-β in breast cancer cells. Oncogene doi: 10.1038/sj.onc.1208713.
31. Wang, Y., and Becker, D. (1997). Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med. 3, 887-893.
32. Wang, Y., Rao, U., Mascari, R., Richards, T., Panson, A., Edington, H., Shipe-Spotloe, J., Donnelly, S., Kirkwood, J., and Becker, D. (1996). Molecular analysis of melanoma precursor lesions. Cell Growth Differ. 7, 1733-1740.
33. Yayon, A., Ma, Y., Safran, M., Klagsbrun, M., and Halaban, R. (1997). Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src- family kinases. Oncogene 14, 2999-3009.